Related Experiment Videos
Market structure and drug innovation
Fabio Pammolli1, Massimo Riccaboni
1Center for Economic Analysis of Competitiveness, Markets, and Regulation, University of Florence.
Health Affairs (Project Hope)
|March 9, 2004
Summary
Technological advances are transforming drug research and development (R&D), but rising costs and cost containment policies are impacting pharmaceutical industry dynamics. This analysis explores these key trends.
Area of Science:
- Pharmaceutical industry
- Health economics
- Biotechnology
Background:
- Modern drug research and development (R&D) has seen significant advancements in knowledge, tools, and technologies.
- Concurrently, escalating healthcare and prescription drug expenditures have led to the implementation of cost containment policies.
- These policies are increasingly restricting drug demand across major global markets.
Purpose of the Study:
- To explore the complex interplay between technological progress and regulatory policies in the pharmaceutical sector.
- To analyze the potential impact of these forces on the future dynamics of the pharmaceutical industry.
Main Methods:
- This perspective synthesizes current trends and expert analysis.
- It involves a review of technological advancements in drug R&D.
- It examines the influence of evolving cost containment policies.
Main Results:
- Technological innovation is driving significant changes in drug R&D processes.
- Cost containment measures are creating market access challenges and influencing drug demand.
- The pharmaceutical industry faces a dynamic environment shaped by these competing forces.
Conclusions:
- The convergence of technological innovation and regulatory pressures presents both opportunities and challenges for the pharmaceutical industry.
- Understanding this interplay is crucial for navigating the future landscape of drug development and market access.